NEW YORK (S&P Global Ratings) Nov. 14, 2016--S&P Global Ratings today assigned its 'A-' issue-level rating to AbbVie Inc.'s announced offering of euro-denominated, senior unsecured notes, to be issued in three tranches maturing in 2019, 2024, and 2029. The company will use proceeds from the offering to repay all or part of its 1.75% senior unsecured notes due Nov. 6, 2017, as well as for general corporate purposes. The transaction does not affect our 'A-' corporate credit and senior unsecured debt ratings or our stable outlook on AbbVie, as we expect the transaction to be essentially leverage neutral. We believe the company maintains a comfortable leverage cushion, in excess of $3 billion, growing to more than $10 billion by 2017,
